Meta-analysis: the efficacy and safety of combined treatment with ARB and ACEI on diabetic nephropathy

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

(2013) Linda F. Fried et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial

(2012) Gema Fernandez Juarez et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes

(2012) Johannes F.E. Mann et al.   JOURNAL OF HYPERTENSION

ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial

(2011) S.M. Titan et al.   CLINICAL NEPHROLOGY

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

(2011) E. Imai et al.   DIABETOLOGIA

Telmisartan, ramipril, or both in patients at high risk for vascular events

(2008) Donald G. Vidt   CURRENT HYPERTENSION REPORTS

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET